Related Experiment Video
Updated: Jun 17, 2026

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
Published on: June 30, 2014
Cognitive impairment after three decades of multiple sclerosis
C Smestad1, L Sandvik, N I Landrø
1Department of Neurology, Oslo University Hospital, Ullevål, Oslo, Norway. smec@uus.no
Background:
Population-based studies of cognitive impairment in patients with multiple sclerosis (MS) with long disease duration are limited. The aim of this study was to evaluate long-term outcome and the predictors of cognitive impairment in a cohort of patients with MS.
Methods:
Patients living in Oslo, Norway, with definite MS and onset in 1940-1980 alive on 1 May 2006 were included. Disability was assessed by Expanded Disability Status Scale (EDSS). Cognitive functioning was assessed in terms of psychomotor speed, attention, learning/memory and executive functions.
Results:
A total of 123 patients was included. EDSS was < or =3.0 in 26% and > or =6.0 in 60% after mean disease duration of 34.5 years. Cognitive impairment was found in 48% of the patients eligible for neuropsychological evaluation (n = 84). Typical pattern was moderate impairment within areas of information processing, attention and memory. In the univariate analysis, younger onset age was significantly associated with cognitive impairment (P = 0.014). Younger onset age (P = 0.017) and disease course (secondary progressive vs. relapsing-remitting MS, P = 0.049) were significantly associated with cognitive impairment in the multivariate analysis.
Conclusions:
After three decades of disease, half of the MS patients experienced reduced cognitive functioning; however, nearly one-third of the patients were only mildly disabled based on the EDSS. Younger onset age was associated with higher prevalence of cognitive impairment. A thorough evaluation of cognitive function in addition to EDSS is essential for evaluating long-term impairment in patients with MS.
Related Concept Videos
Multiple Sclerosis l: Introduction
Cognitive Development During Adulthood
Dementia l: Introduction
Alzheimer Disease l: Introduction
Language and Cognition
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

